13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 33 holding rows worth $395,567,000.
- Accession
- 0001140361-17-020690
- Filer
- CIK 1587114
- Filed
- 2017-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 33 entries on the cover page, a total value of $395,567,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $395,567,000 with VALUE read as thousands by filing date, 13F file number 028-16764. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,943,164 | $75,021,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 2,905,515 | $49,568,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 551,041 | $47,494,000 | thousands by filing date | |
| GILEAD SCIENCES INC | 375558903 | COM | 500,000 | $33,960,000 | thousands by filing date | call |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,025,700 | $28,720,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 2,611,906 | $22,985,000 | thousands by filing date | |
| THERAVANCE INC | 88338TAB0 | CORPORATE OBLIG | 17,000,000 | $21,441,000 | thousands by filing date | principal |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 673,100 | $20,072,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 794,969 | $13,729,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B606 | COM NEW | 3,000,000 | $12,420,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,537,026 | $11,543,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 434,812 | $8,935,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 2,292,659 | $8,024,000 | thousands by filing date | |
| OVASCIENCE INC | 69014Q101 | COM | 3,512,332 | $6,568,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 258,457 | $5,683,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 234,813 | $5,617,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 544,880 | $3,841,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 264,773 | $3,177,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K951 | PUT | 1,510,000 | $2,492,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 874,447 | $2,361,000 | thousands by filing date | |
| VERSARTIS INC | 92529L102 | COM | 100,000 | $2,135,000 | thousands by filing date | |
| VIVEVE MED INC | 92852W204 | COM NEW | 250,000 | $1,583,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 23,300 | $1,361,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031908 | CALL | 382,000 | $1,299,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 42,009 | $1,036,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 63,596 | $1,013,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 17,060 | $928,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 01683L106 | COM | 118,000 | $859,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 35,301 | $484,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC | 14740B906 | COM NEW | 103,800 | $430,000 | thousands by filing date | call |
| OREXIGEN THERAPEUTICS INC COM NEW | 686164302 | Stock | 117,726 | $405,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 10,000 | $275,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 5,025 | $108,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-17-020690 | this filing | 2017-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001140361-17-021481 | base | 2017-05-19 | acceptance time not in the bulk data set |